ArticleFrontiers in endocrinology2021

Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.

Neil Tanday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.